It can take a long time to create a new vaccine and at the same time, there have been many evolutions and new strains of the ...
Researchers in Kingston, Ont., are embarking upon a clinical trial that will look at whether very small doses of psilocybin — ...
I gave dozens of tours and talked to hundreds of prospective students in the three years that I was a tour guide. Students ...
TipRanks on MSN
Nervgen Pharma’s NVG-291 Study: A Potential Breakthrough in Spinal Cord Injury Treatment
Detailed price information for Nervgen Pharma Corp (NGENF) from The Globe and Mail including charting and trades.
Kingston researchers are leading Canada’s first Health Canada–approved clinical trial testing at-home psilocybin microdosing for anxiety.The study, led by Dr. Claudio Soares, a professor at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results